Skip to main content

MWG Biotech Chairman to Retire

NEW YORK, Aug. 30 (GenomeWeb News) - MWG Biotech said today that the company's management board chairman, Thomas Becker, will resign at the end of the month.

 

According to the company, Becker cited personal reasons for his decision to resign. While a successor is being sought, board members Wolfgang Pieken and Volker Muschalek will manage the company.

 

MWG said that its supervisory board "regrets Thomas Becker's decision," but that the company's goals for 2004 - a moderate increase in sales and a positive EBITDA, and a break-even cash flow - are "still realistic."

 

The Scan

And For Adolescents

The US Food and Drug Administration has authorized the Pfizer-BioNTech SARS-CoV-2 vaccine for children between the ages of 12 and 15 years old.

Also of Concern to WHO

The Wall Street Journal reports that the World Health Organization has classified the SARS-CoV-2 variant B.1.617 as a "variant of concern."

Test for Them All

The New York Times reports on the development of combined tests for SARS-CoV-2 and other viruses like influenza.

PNAS Papers on Oral Microbiome Evolution, Snake Toxins, Transcription Factor Binding

In PNAS this week: evolution of oral microbiomes among hominids, comparative genomic analysis of snake toxins, and more.